NCT03145415

Brief Summary

The purpose of this randomized blinded prospective study is to compare the analgesic efficacy and duration of a Pudendal Nerve Block (PNB) to a Caudal Block (CB) for pediatric patients, ages 6 months to 2 years, undergoing hypospadias repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

May 19, 2022

Status Verified

April 1, 2017

Enrollment Period

2.8 years

First QC Date

May 3, 2017

Last Update Submit

May 17, 2022

Conditions

Keywords

pudendal nerve blockhypospadiascaudal block

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption

    The child's care giver will document the times that a rescue opioid was given to relieve pain.

    up to 24 hours

Secondary Outcomes (2)

  • Intraoperative block assessment

    up to 3 hours

  • Post operative pain

    up to 2 hours

Study Arms (2)

Bilateral Pudendal block

EXPERIMENTAL

0.25 cc per kg of 0.2% ropivacaine will be injected once for right pudendal N block and the same volume for the left pudendal N block before the start of the surgery

Procedure: Bilateral Pudendal block

Caudal block

ACTIVE COMPARATOR

1 cc per kg of 0.2% ropivacaine in the caudal space given before the start of surgery

Procedure: Caudal block

Interventions

Caudal blockPROCEDURE

1 cc per kg of 0.2% ropivicaine in the caudal space given before the start of surgery.

Caudal block

0.5 cc per kg of 0.2% ropivicaine. Half of the volume given as a right pudendal block and the remaining volume given on the left pudendal nerve block given prior to the start of surgery

Bilateral Pudendal block

Eligibility Criteria

Age6 Months - 2 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Boys undergoing hypospadias repair

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours/ duPont Hospital for Children

Wilmington, Delaware, 19803, United States

Location

Related Publications (1)

  • Choudhry DK, Heredia L, Brenn BR, Brown M, Carvalho NF, Whaley MC, Shaik SS, Hagerty JA, Bani Hani A. Nerve stimulation guided bilateral pudendal nerve block versus landmark-based caudal block for hypospadias repair in young children: a prospective, randomized, pragmatic trial. Reg Anesth Pain Med. 2022 Dec;47(12):744-748. doi: 10.1136/rapm-2022-103680. Epub 2022 Sep 8.

MeSH Terms

Conditions

HypospadiasEpispadias

Condition Hierarchy (Ancestors)

Urogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesUrethral DiseasesUrologic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
No other parties will be masked.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: All Children will be randomly assigned to one of 2 groups of 30 patients each using a computer generated number table.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2017

First Posted

May 9, 2017

Study Start

February 17, 2017

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

May 19, 2022

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations